Atorvastatin lactone
- CAS No.
- 125995-03-1
- Chemical Name:
- Atorvastatin lactone
- Synonyms
- 5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide;PD-130694;ATORVASTATIN LACTONE;Atorvastatin USP RC H;Atorvastatin calcium-6;Atorvastatin d-Lactone;Atorvastatin Impurity H;LACTONE IMPURITY(IMP-H);(RS) Atorvastatin Lactone;Atorvastatin lactone ,97%
- CBNumber:
- CB4313438
- Molecular Formula:
- C33H33FN2O4
- Molecular Weight:
- 540.62
- MDL Number:
- MFCD00899262
- MOL File:
- 125995-03-1.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Atorvastatin Related Compound H Pharmaceutical Secondary Standard; Certified Reference Material | PHR1873 | 30 mg | $793 |
| Atorvastatin Related Compound H United States Pharmacopeia (USP) Reference Standard | 1044582 | 20MG | $1290 |
| Atorvastatin Lactone >95.0%(HPLC) | A3114 | 25mg | $122 |
| Atorvastatin Lactone >95.0%(HPLC) | A3114 | 100mg | $362 |
| Atorvastatin lactone ≥95% | 20951 | 1mg | $36 |
| More product size | |||
| Melting point | 103-106°C |
|---|---|
| alpha | D +26.05° (c = 1 in chloroform) |
| Boiling point | 674.8±55.0 °C(Predicted) |
| Density | 1.24±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,2-8°C |
| solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |
| pka | 13.39±0.40(Predicted) |
| form | Solid |
| color | White to Light Yellow |
| optical activity | Consistent with structure |
| Merck | 14,864 |
| Major Application | pharmaceutical (small molecule) |
| InChIKey | OUCSEDFVYPBLLF-KAYWLYCHSA-N |
| SMILES | Fc1ccc(cc1)c2[n](c(c(c2c5ccccc5)C(=O)Nc4ccccc4)C(C)C)CC[C@H]3OC(=O)C[C@@H](C3)O |
| FDA UNII | 7876IL7J2N |
| UNSPSC Code | 41116107 |
| NACRES | NA.24 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H315-H319-H335 | |||||||||
| Precautionary statements | P261-P305+P351+P338 | |||||||||
| WGK Germany | WGK 3 | |||||||||
| HS Code | 2933.99.7500 | |||||||||
| Storage Class | 11 - Combustible Solids | |||||||||
| NFPA 704 |
|
Atorvastatin lactone price More Price(41)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | PHR1873 | Atorvastatin Related Compound H Pharmaceutical Secondary Standard; Certified Reference Material | 125995-03-1 | 30 mg | $793 | 2026-04-30 | Buy |
| Sigma-Aldrich | 1044582 | Atorvastatin Related Compound H United States Pharmacopeia (USP) Reference Standard | 125995-03-1 | 20MG | $1290 | 2026-04-30 | Buy |
| TCI Chemical | A3114 | Atorvastatin Lactone >95.0%(HPLC) | 125995-03-1 | 25mg | $122 | 2026-04-30 | Buy |
| TCI Chemical | A3114 | Atorvastatin Lactone >95.0%(HPLC) | 125995-03-1 | 100mg | $362 | 2026-04-30 | Buy |
| Cayman Chemical | 20951 | Atorvastatin lactone ≥95% | 125995-03-1 | 1mg | $36 | 2026-04-30 | Buy |
Atorvastatin lactone Chemical Properties,Uses,Production
Chemical Properties
Slightly Yellow Solid
Uses
Atorvastatin intermediate as inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation
Uses
Atorvastatin Lactone (Atorvastatin EP Impurity H) is an intermediate of Atorvastatin, a inhibitor of MAP kinase and/or HMG-CoA reductase for the treatment of inflammation.
Synthesis
134523-03-8
125995-03-1
Calcium salt of (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid (500 mg, 0.413 mmol) was used as a raw material, which was suspended in water (8 mL), EtOAc (4 mL) was added, and the mixture was cooled in an ice bath (4°C). An aqueous 0.2 M HCl solution (4.55 mL, 0.910 mmol) was added slowly and dropwise under vigorous stirring until a clarified solution was formed. The reaction mixture was gradually warmed to room temperature, followed by separation of the organic and aqueous layers. The aqueous layer was extracted with EtOAc (3 x 5 mL), the combined organic layers were washed with brine (5 mL), dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The resulting foam (469 mg) was dissolved in toluene (20 mL) and the mixture was heated to 0°C and refluxed for 2.5 h under a Dean-Stark apparatus. Upon completion of the reaction, the mixture was cooled to room temperature and concentrated under reduced pressure. Purification by fast column chromatography (eluent: heptane/EtOAc, gradient from 1:3 to 1:5) afforded the target product 5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide (394 mg. (white foamy substance). NMR hydrogen spectrum (400 MHz, CDCl3) δ 7.24-7.10 (m, 9H), 7.09-6.96 (m, 5H), 6.92-6.82 (br s, 1H), 4.57-4.47 (m, 1H), 4.34-4.27 (m, 1H), 4.27-4.16 (m, 1H), 4.09-3.97 (m , 1H), 3.62-3.47 (m, 1H), 2.66 (ABdd, J = 17.7, 4.8 Hz, 1H), 2.55 (ABddd, J = 17.7, 3.4, 1.5 Hz, 1H), 2.11 (d, J = 2.9 Hz, 1H), 1.95-1.82 (m, 1H), 1.81-1.67 (m, 2H) , 1.63-1.57 (m, 1H), 1.56-1.45 (m, 6H).
References
[1] Patent: WO2017/137469, 2017, A1. Location in patent: Page/Page column 62
[2] Patent: CN105085497, 2017, B. Location in patent: Paragraph 0115; 0116; 0117
Atorvastatin lactone Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hangzhou ICH Biofarm Co., Ltd | +86-0571-28186870; +undefined8613073685410 | sales@ichemie.com | China | 1006 | 58 |
| Capot Chemical Co.,Ltd. | +86-(0)57185586718; +8613336195806 | sales@capot.com | China | 29640 | 60 |
| Guangzhou PI PI BIOTECH INC | +86-86-020-81716320 +8613602409664 | Sales@pipitech.com | China | 973 | 55 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 33024 | 60 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29819 | 58 |
| Standardpharm Co. Ltd. | 86-714-3992388 | overseasales1@yongstandards.com | United States | 14332 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49977 | 58 |
| SIMAGCHEM CORP | +86-5922680277 +86-13806087780 | sale@simagchem.com | China | 17346 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +17819995354 | marketing@targetmol.com | United States | 32467 | 58 |
| Win-Win chemical CO., Limited | +86-0086-577-64498589 +86-15355981851 | sales@win-winchemical.com | China | 14304 | 58 |
View Lastest Price from Atorvastatin lactone manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-01-04 | 5-(4-fluorophenyl)-2-(1-methyl-ethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro- hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide
125995-03-1
|
US $0.00-0.00 / KG | 1KG | 99% | 500 | Hangzhou ICH Biofarm Co., Ltd | |
![]() |
2025-12-19 | Atorvastatin Impurity H(EP)
125995-03-1
|
US $0.00-0.00 / mg | 10mg | 90%+ | 10g | Guangzhou PI PI BIOTECH INC | |
![]() |
2025-12-19 | Atorvastatin Impurity E Intermediate | US $0.00-0.00 / mg | 10mg | 90%+ | 10g | Guangzhou PI PI BIOTECH INC |
-
![5-(4-fluorophenyl)-2-(1-methyl-ethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro- hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide pictures](/ProductImageEN/2023-07/Small/872ae528-b962-4004-a049-7d5738cec601.png)
- 5-(4-fluorophenyl)-2-(1-methyl-ethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro- hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide
125995-03-1
- US $0.00-0.00 / KG
- 99%
- Hangzhou ICH Biofarm Co., Ltd
-

- Atorvastatin Impurity H(EP)
125995-03-1
- US $0.00-0.00 / mg
- 90%+
- Guangzhou PI PI BIOTECH INC
-

- Atorvastatin Impurity E Intermediate
- US $0.00-0.00 / mg
- 90%+
- Guangzhou PI PI BIOTECH INC





